NGeneBio Completes Full Payment of KRW 7.6791 Billion Rights Offering

Asahi Kasei Wins FDA Approval for New Herpes Drug Hovlpri for Immunocompromised Adults

Mirum’s Livmarli succeeds in phase 3 trial, company seeks expanded indication for rare liver disease

Roche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027

BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors

Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”

CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count